服(fú)務熱(rè)綫:

產品(pǐn)簡(jiǎn)介(jiè)
天津益元利康(kāng)科(kē)技(jì)有限(xiàn)公司是Integral Molecular代理Integral Molecular 是(shì)一家研(yán)究驅動的(dí)生物(wù)技術(shù)公(gōng)司,為未充(chōng)分利用(yòng)的(dí)膜蛋白(bái)靶(bǎ)標創造創(chuàng)新技(jì)術(shù)和(hé)治療性(xìng)抗體,包括 GPCR,離子通道,轉運蛋白和(hé)病(bìng)毒(dú)包(bāo)膜。公司使命是(shì)開發和應(yīng)用創(chuàng)新(xīn)技(jì)術,推動針對困難(nán)蛋白質靶標的(dí)治(zhì)療(liáo)發(fā)現(xiàn)。 憑(píng)借 20 多年專注於膜蛋(dàn)白(bái)和(hé)抗體(tǐ)的經(jīng)驗(yàn),我們(mén)的技(jì)術(shù)已為 400 多(duō)家從事(shì)研(yán)究,藥物發(fā)現和(hé)疫(yì)苗開發(fā)的公(gōng)
產(chǎn)品(pǐn)分類(lèi)
Integral Molecular 是一(yī)家(jiā)研究驅動的生物(wù)技術公司(sī),為未充(chōng)分利用(yòng)的膜(mó)蛋白靶標創(chuàng)造創(chuàng)新技術和治(zhì)療性抗(kàng)體,包(bāo)括(kuò) GPCR,離子通(tōng)道,轉運蛋(dàn)白和病毒包膜。公(gōng)司使(shǐ)命是開發和應(yīng)用(yòng)創新(xīn)技(jì)術(shù),推動(dòng)針對困(kùn)難蛋(dàn)白質(zhì)靶標的治療(liáo)發現(xiàn)。 憑(píng)借(jiè) 20 多(duō)年(nián)專注(zhù)於膜蛋白和(hé)抗體的經(jīng)驗,我們的技術(shù)已為(wéi) 400 多(duō)家從事研(yán)究,藥(yào)物發現和疫(yì)苗開(kāi)發的公司提供支持。
Integral Molecular針對復雜膜(mó)蛋白(bái)(包(bāo)括 GPCR,離(lí)子(zǐ)通道,轉運蛋白和病毒(dú)蛋(dàn)白)分(fēn)離 MAb 的成(chéng)功率(shuài)為 95%,並(bìng)且在(zài)分離和表征復(fù)雜膜蛋(dàn)白方(fāng)麵擁有 15 年以上的經(jīng)驗。Integral Molecular代理
Integral Molecular產品列(liè)表:Integral Molecular代理
種類 | 受體 | 名(míng)稱 | 貨(huò)號 |
GPCR | A2AR | Alpha Adrenergic | RR-0910 |
B2AR | Beta Adrenergic | RR-0574 | |
CCR1 | Chemokine | RR-0968 | |
CCR2b | Chemokine | RR-0125 | |
hCCR5 | Chemokine | RR-0190 | |
mCCR5 | Chemokine | RR-0835 | |
rhCCR5 | Chemokine | RR-0895 | |
CCR6 | Chemokine | RR-0822 | |
CCR10 | Chemokine | RR-0193 | |
CXCR2 | Chemokine | RR-0943 | |
CXCR3 | Chemokine | RR-0132 | |
CXCR4 | Chemokine | RR-0830 | |
CXCR7 | Chemokine | RR-0656 | |
mCXCR4 | Chemokine | RR-2194 | |
GLP-1R | Glucagon-like peptide-1 Receptor | RR-1090 | |
GCGR | Glucagon Receptor | RR-0999 | |
GAL1 Receptor | Neuropeptide Receptor | RR-1067 | |
5-HT2C | Serotonin Receptor | RR-1498 | |
FZD4 | Wnt Pathway | RR-1302 | |
Ion Channel | HV1 | Voltage Gated H+ | RR-0678 |
TRPC4 | Nonspecific Cation Channel | RR-1054 | |
TRPM4 | Nonspecific Cation Channel | RR-1333 | |
K2P1.1 | Potassium Channel | RR-1225 | |
K2P4.1 | Potassium Channel | RR-1331 | |
P2X2 | ATP Purinoceptor | RR-1181 | |
Transporter | GLUT1 | Glucose Transporter | RR-0777 |
RTK | ALK2 | Activin Receptor | RR-0850 |
1-TM 1-TM | ACVR1 | Activin A Receptor,Type I | RR-0850 |
CD19C | B-Cell Activation | RR-0553 | |
CD27C | B-Cell Activation | RR-0655 | |
DC-SINGC | Lectin | RR-0057 | |
DC-SINGR | Lectin | RR-0056 | |
LRP6C | Wnt Pathway | RR-0853 | |
hTL1A | TNF Ligand | RR-0819 | |
mTL1A | TNF Ligand | RR-0817 | |
ST2L | IL-1 Receptor Familly | RR-0653 | |
4-TM | CD81 | Hepatitis C Attachment | RR-0341 |
CD20 | B-Cell Activation | RR-1179 | |
Claudin-1 | Tight Junction | RR-0825 | |
Claudin-2 | Tight Junction | RR-0733 | |
Claudin-3 | Tight Junction | RR-0686 | |
Viral Protein | RSV-F | Respiratory Syncytial Virus | RR-0891 |
Influenza M2 A/Udorn/307/1972 | Ion Channel | RR-0929 | |
Influenza M2 A/HK/156/1997 | Ion Channel | RR-0179 | |
Chikungunya Virus | Viral Envelope | RR-0945 | |
Ross River Virus | Viral Envelope | RR-1136 |
掃碼(mǎ)加(jiā)微信